Ethyl 2-((tert-butoxycarbonyl)amino)-3-nitrobenzoate, 95.0%, 500g

(S)-Pyrrolidin-2-ylmethanamine dihydrochloride, 95.0%, 5g

EZATIOSTAT, 95%, 5mg

3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole, 95.0%, 1g

3-(2-methyl-1H-imidazol-1-yl)propanoic acid hydrochloride, 95.0%, 1g

tert-Butyl Methyl Ether>99.0%(GC)25mL

1-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

N-(2-Chloro-phenyl)-2-hydroxy-benzamide, 95.0%, 1g

[1-(3-bromophenyl)cyclobutyl]methanamine, 95.0%, 100mg

N-Boc-2-(4-trifluoromethyl-phenyl)-DL-glycine, 97.0%, 10g

2-Chloro-6-methylbenzonitrile, 95.0%, 25g

3-BROMO-1-METHYL-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 5g

4,8-Dichloroquinoline-3-carboxylic acid, 95+%, 100mg